Wave Life Sciences .-Wave Life Sciences (WVE) Reports Q2 Loss, Misses Revenue Estimates

Wave Life Sciences (WVE) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of$ 0.29. This compares to a loss of $0.25 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -6.90%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of$ 0.27 per share when it actually produced a loss of $0.29, delivering a surprise of -7.41%.Over the last four quarters, th ...